Starling Oncology, Inc.
STLN Healthcare Medical Care Facilities
Starling Oncology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.7 million, up 27.8% from fiscal 2024. In the quarter to June 2026, revenue grew 34.6%, EPS grew 46.7%, free cash flow grew 196.7% and total debt rose 6.46%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow STLN
Starling Oncology, Inc. (STLN) EV/Sales
As of 16 October 2026, Starling Oncology, Inc. (STLN) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 0.0× (December 2021) to 3.1× (May 2022); the current reading is higher than 86% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.7× | 336.10% |
| FY2024 | 0.2× | (68.26%) |
| FY2023 | 0.5× | 8.97% |
| FY2022 | 0.5× | (81.42%) |
| FY2021 | 2.6× | — |
| FY2020 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.0× | 54.04% |
| Mar 2026 | 0.7× | (10.83%) |
| Dec 2025 | 0.7× | (12.06%) |
| Sep 2025 | 0.8× | 51.68% |
| 18 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MCTA Charming Medical Limited compare | n/m |
| HCSG Healthcare Services Group, Inc. compare | 0.7× |
| CYH Community Health Systems, Inc. compare | 0.8× |
| AUNA Auna S.A. compare | 1.0× |
| INNV InnovAge Holding Corp. compare | 1.1× |
| STLN Starling Oncology, Inc. | 1.2× |
| SRTA Strata Critical Medical, Inc. compare | 1.4× |
| NUTX Nutex Health Inc. compare | 1.6× |
| USPH U.S. Physical Therapy, Inc. compare | 1.8× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)